Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Prostatic Neoplasms 2Castration Resistant Metastatic Prostate Cancer 2Uterine Cervical Neoplasms 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Fatigue 1Castration-resistant Prostate Cancer 1Castration-Resistant Prostate Carcinoma 1Carcinoma, Squamous Cell 1Cachexia 1

Interventions

Cisplatin 76Radiotherapy 44pembrolizumab 39Cetuximab 38Paclitaxel 34Carboplatin 33Docetaxel 30Fluorouracil 25Radiotherapy, Intensity-Modulated 22Nivolumab 18Drug Therapy 14Radiation 12Erlotinib Hydrochloride 9cemiplimab 8Magnetic Resonance Spectroscopy 8130-nm albumin-bound paclitaxel 8durvalumab 7atezolizumab 7Cyclophosphamide 7Afatinib 7Surgical Procedures, Operative 6Panitumumab 6Leucovorin 6Chemoradiotherapy 6fludarabine 5aldesleukin 5Radiosurgery 5Oxaliplatin 5Methotrexate 5Gemcitabine 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Squamous Cell × testosterone enanthate × Clear all
NCT00878995 2018-03-12

Testosterone for Treating Cachexia in Patients With Squamous Cell Carcinoma

The University of Texas Medical Branch, Galveston

Phase 1 Completed
28 enrolled 55 charts
Gynecologic

Cachexia, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡